Claudel Sophie E, Waikar Sushrut S, Schmidt Insa M, Vasan Ramachandran S, Verma Ashish
Department of Internal Medicine, Boston Medical Center, Boston, MA, USA.
Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
medRxiv. 2023 Dec 24:2023.12.21.23300378. doi: 10.1101/2023.12.21.23300378.
Albuminuria is associated with cardiovascular events among adults with underlying cardiovascular disease and diabetes, even at low levels of urinary albumin excretion. We hypothesized that low levels of albuminuria in the 'normal' range (urinary albumin-to-creatine ratio (UACR) <30 mg/g) are associated with cardiovascular death among apparently healthy adults.
We studied adults who participated in the 1999-2014 National Health and Nutrition Examination Survey. We excluded participants with baseline cardiovascular disease, hypertension, diabetes, estimated glomerular filtration rate (eGFR) <60ml/min/1.73m, those who were currently pregnant, and those who had received dialysis in the last year. After excluding these conditions, only 5.0% of the remaining population had UACR ≥30 mg/g (N=873) and were excluded. The final sample size was 16,247. We assessed the relationship between UACR and cardiovascular and all-cause mortality using multivariable-adjusted Cox proportional hazards models. Models were adjusted for age, sex, race or ethnicity, smoking status, systolic blood pressure, hemoglobin A1c, total cholesterol, health insurance, food insecurity, serum albumin, body mass index, use of statins, and eGFR.
Mean age was 38.9 years (SD 13.6) and 53.7% were women. The median length of follow-up was 12.2 years. In multivariable-adjusted models, each doubling of UACR (within the <30 mg/g range) was associated with a 36% higher risk of cardiovascular death [HR 1.36 (95% confidence interval (CI) 1.11-1.65)] and a 28% higher risk of all-cause mortality [HR 1.28 (95%CI 1.17-1.41)]. The highest tertile of UACR (7.1-29.9 mg/g) was associated with an 87% higher risk of cardiovascular death [HR 1.87 (95%CI 1.20-2.92)] and 59% higher risk of all-cause mortality [HR 1.59 (95%CI 1.28-1.96)], compared with the lowest tertile (< 4.3 mg/g).
In a nationally representative sample of relatively healthy community-dwelling adults, higher levels of albuminuria in the conventionally "normal" range <30 mg/g in healthy individuals are associated with greater mortality. Overall, our findings contribute to the growing body of evidence on the existence of a risk gradient across all levels of albuminuria, even in the so-called normal range.
在患有潜在心血管疾病和糖尿病的成年人中,蛋白尿与心血管事件相关,即使尿白蛋白排泄水平较低。我们推测,在看似健康的成年人中,处于“正常”范围内的低水平蛋白尿(尿白蛋白与肌酐比值(UACR)<30mg/g)与心血管死亡相关。
我们研究了参加1999 - 2014年美国国家健康和营养检查调查的成年人。我们排除了有基线心血管疾病、高血压、糖尿病、估计肾小球滤过率(eGFR)<60ml/min/1.73m²的参与者,当前怀孕的女性,以及过去一年接受过透析的人。排除这些情况后,剩余人群中只有5.0%的人UACR≥30mg/g(n = 873)并被排除。最终样本量为16247。我们使用多变量调整的Cox比例风险模型评估UACR与心血管和全因死亡率之间的关系。模型对年龄、性别、种族或族裔、吸烟状况、收缩压、糖化血红蛋白、总胆固醇、健康保险、粮食不安全状况、血清白蛋白、体重指数、他汀类药物的使用以及eGFR进行了调整。
平均年龄为38.9岁(标准差13.6),女性占53.7%。中位随访时间为12.2年。在多变量调整模型中,UACR每增加一倍(在<30mg/g范围内),心血管死亡风险增加36%[风险比(HR)1.36(95%置信区间(CI)1.11 - 1.65)],全因死亡风险增加28%[HR 1.28(95%CI 1.17 - 1.41)]。与最低三分位数(<4.3mg/g)相比,UACR最高三分位数(7.1 - 29.9mg/g)的心血管死亡风险高87%[HR 1.87(95%CI 1.20 - 2.92)],全因死亡风险高59%[HR 1.59(95%CI 1.28 - 1.96)]。
在一个具有全国代表性的相对健康的社区居住成年人样本中,健康个体中传统上“正常”范围<30mg/g内较高水平的蛋白尿与更高的死亡率相关。总体而言,我们的研究结果为越来越多的证据提供了补充,证明即使在所谓的正常范围内,蛋白尿各水平之间也存在风险梯度。